Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
lungcanc
Evolution of Research Using Patient-Reported Outcomes in Lung Cancer: A Q&A...
lungcanc
Sublobar Resections for Early Lung Cancer
lungcanc
TTFields in Unresectable MPM: STELLAR Results in Practice
lungcanc
On the Backs of Specialists: LDCT Screening Has Heightened the Importance...
lungcanc
‘Never Too Late’: Tobacco Cessation Programs Benefit Patients With Cancer
lungcanc
Stage IIIA NSCLC: A Review of Recent and Ongoing Trials Trial
lungcanc
Oncology Trials Could Benefit From Increased Data on Tobacco Use
lungcanc
TTFields in Mesothelioma (The STELLAR Trial): More Stars Needed in the...
lungcanc
Lung Cancer in the Brazilian Health System: Screening, Drug Approvals, Barriers...
lungcanc
1
...
3
4
5
...
53
Page 4 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
